Fujian Acetron New Materials Co., Ltd.

Fujian Acetron New Materials Co., Ltd. is a Chinese enterprise primarily engaged in the research, development, production, and sale of advanced materials used in vacuum evaporation and sputter coating processes. Its comprehensive product range includes specialized compounds, fluoride and oxide materials, various targets, metal and alloy components, organic substances, and coating accessories, predominantly for the optics and optical communication industries, along with sulfide and other material types. The company also manufactures targets specifically engineered for diverse applications such as films for building and automotive glass, flat panel displays, solar energy/photovoltaic installations, and decorative or tool coatings. While operating mainly within China, Fujian Acetron extends its market reach globally, exporting products primarily to Japan, the United States, Germany, and Korea. The firm was established in 2002 and maintains its headquarters in Changle, China.

Fujian Acetron New Materials Co., Ltd. trades as 300706.SZ on SHZ. The company is classified in Basic Materials / Chemicals and reports in CNY.

The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Fujian Acetron New Materials Co., Ltd. can be compared against peers such as Anhui Guofeng New Materials Co., Ltd., ZETTA Group Co., Ltd. Class A, Great Chinasoft Technology Co.,Ltd., Shanghai Anoky Group Co., Ltd, Jiangsu Changhai Composite Materials Co., Ltd, Lecron Industrial Development Group Co., Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $8.67B, beta of 0.96, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

300706.SZ currently shows total debt of N/A and beta of 0.96. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.acetron.com.cn

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.